Overview

Esomeprazole and Radiation Induced Esophagitis

Status:
Recruiting

Trial end date:
2028-01-31

Target enrollment:

Participant gender:

Summary

Thoracic radiation therapy combined with chemotherapy (with or without immunotherapy) is the cornerstone of management in patients with locally advanced non-small cell lung cancer (NSCLC).

Phase:

Phase 2

Details

Lead Sponsor:

Rush University Medical Center

Treatments:

Esomeprazole